CIPLA FDA Approval ANDA 204843

ANDA 204843

CIPLA

FDA Drug Application

Application #204843

Application Sponsors

ANDA 204843CIPLA

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)0DEXMEDETOMIDINE HYDROCHLORIDEDEXMEDETOMIDINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2019-01-18STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

HONG KONG
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204843
            [companyName] => HONG KONG
            [docInserts] => ["",""]
            [products] => [{"drugName":"DEXMEDETOMIDINE HYDROCHLORIDE","activeIngredients":"DEXMEDETOMIDINE HYDROCHLORIDE","strength":"EQ 200MCG BASE\/2ML (EQ 100MCG BASE\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/18\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-01-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.